Neurocognitive functioning in adults with trichotillomania: Predictors treatment response and symptom severity in a randomized control trial

被引:1
|
作者
Barber, Kathryn E. [1 ]
Woods, Douglas W. [1 ]
Deckersbach, Thilo [2 ]
Bauer, Christopher C. [3 ]
Compton, Scott N. [4 ]
Twohig, Michael P. [5 ]
Ricketts, Emily J. [6 ]
Robinson, Jordan [7 ]
Saunders, Stephen M. [1 ]
Franklin, Martin E. [8 ]
机构
[1] Marquette Univ, Dept Psychol, 317 604 N 16th St, Milwaukee, WI 53233 USA
[2] Univ Appl Sci, DIPLOMA Hsch, Am Hegeberg 2, D-37242 Bad Sooden Allendorf, Germany
[3] Med Coll Wisconsin, Hlth Resource Ctr, 8701 Watertown Plank Rd,5th Floor, Milwaukee, WI 53226 USA
[4] Duke Univ, Duke Child & Family Study Ctr, Dept Psychiat & Behav Sci, 2608 Erwin Rd, Durham, NC 27705 USA
[5] Utah State Univ, Dept Psychol, 2810 Old Main Hill, Logan, UT 84322 USA
[6] UCLA Semel Inst, Dept Neurosci, 1506 Gonda Ctr Angeles, Los Angeles, CA 90095 USA
[7] JSR Neuropsychol Serv, 3209 W 76th St, Edina, MN 55435 USA
[8] Rogers Behav Hlth, 1 Winding Dr, Suite 106, Philadelphia, PA 19131 USA
基金
美国国家卫生研究院;
关键词
Trichotillomania; Response inhibition; Inhibitory control; Cognitive flexibility; Neurocognition; Neuropsychology; OBSESSIVE-COMPULSIVE DISORDER; MGH HAIRPULLING SCALE; OBJECT ALTERNATION; NEUROPSYCHOLOGICAL PREDICTORS; COGNITIVE FLEXIBILITY; MOTOR INHIBITION; STOP-SIGNAL; IMPAIRMENT; METAANALYSIS; IMPROVEMENT;
D O I
10.1016/j.brat.2024.104556
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Trichotillomania (TTM) is associated with impairments in response inhibition and cognitive flexibility, but it unclear how such impairments relate to treatment outcome. The present study examined pre-treatment response inhibition and cognitive flexibility as predictors of treatment outcome, change in these domains from pre-to posttreatment, and associations with TTM severity. Participants were drawn from a randomized controlled trial comparing acceptance-enhanced behavior therapy (AEBT) to psychoeducation and supportive therapy (PST) for TTM. Adults completed assessments at pre-treatment (n n = 88) and following 12 weeks of treatment (n n = 68). Response inhibition and cognitive flexibility were assessed using the Stop Signal Task and Object Alternation Task, respectively. Participants completed the MGH-Hairpulling Scale. Independent evaluators administered the NIMH-Trichotillomania Severity Scale and Clinical Global Impressions-Improvement Scale. Higher pre-treatment TTM severity was associated with poorer pre-treatment cognitive flexibility, but not response inhibition. Better pre-treatment response inhibition performance predicted positive treatment response and lower post-treatment TTM symptom severity, irrespective of treatment assignment. Cognitive flexibility did not predict treatment response. After controlling for age, neither neurocognitive variable changed during treatment. Response inhibition and cognitive flexibility appear uniquely related to hair pulling severity and treatment response in adults with TTM. Implications for treatment delivery and development are discussed.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Markers of severity and predictors of response to treatment in severe asthma
    Sese, L.
    Mahay, G.
    Barnig, C.
    Guibert, N.
    Leroy, S.
    Guilleminault, L.
    REVUE DES MALADIES RESPIRATOIRES, 2022, 39 (09) : 740 - 757
  • [43] A longitudinal investigation of cognitive functioning and its relationship to symptom severity and academic functioning in treatment seeking youth with AHDH
    Tallberg, Pia
    Rastam, Maria
    Perrin, Sean
    Hallin, Anne-Li
    Gustafsson, Peik
    SCANDINAVIAN JOURNAL OF CHILD AND ADOLESCENT PSYCHIATRY AND PSYCHOLOGY, 2021, 9 : 52 - 63
  • [44] Effect of Oral Prednisolone on Symptom Duration and Severity in Nonasthmatic Adults With Acute Lower Respiratory Tract Infection A Randomized Clinical Trial
    Hay, Alastair D.
    Little, Paul
    Harnden, Anthony
    Thompson, Matthew
    Wang, Kay
    Kendrick, Denise
    Orton, Elizabeth
    Brookes, Sara T.
    Young, Grace J.
    May, Margaret
    Hollinghurst, Sandra
    Carroll, Fran E.
    Downing, Harriet
    Timmins, David
    Lafond, Natasher
    El-Gohary, Magdy
    Moore, Michael
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (08): : 721 - 730
  • [45] Optimal Omeprazole Dosing and Symptom Control: A Randomized Controlled Trial (OSCAR Trial)
    Waghray, Abhijeet
    Waghray, Nisheet
    Perzynski, Adam
    Votruba, Mark
    Wolfe, M. Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S606 - S606
  • [46] Optimal Omeprazole Dosing and Symptom Control: A Randomized Controlled Trial (OSCAR Trial)
    Waghray, Abhijeet
    Waghray, Nisheet
    Perzynski, Adam T.
    Votruba, Mark
    Wolfe, M. Michael
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (01) : 158 - 166
  • [47] Optimal Omeprazole Dosing and Symptom Control: A Randomized Controlled Trial (OSCAR Trial)
    Abhijeet Waghray
    Nisheet Waghray
    Adam T. Perzynski
    Mark Votruba
    M. Michael Wolfe
    Digestive Diseases and Sciences, 2019, 64 : 158 - 166
  • [48] Optimal Omeprazole Dosing and Symptom Control - A Randomized Controlled Trial (OSCAR Trial)
    Waghray, Abhijeet
    Waghray, Nisheet
    Perzynski, Adam T.
    Wolfe, M. M.
    GASTROENTEROLOGY, 2016, 150 (04) : S477 - S478
  • [49] A randomised control trial of individual neurocognitive remediation:: The effects on cognitive deficits & general functioning
    Wykes, T
    Reeder, C
    Corner, J
    Williams, C
    Everitt, B
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 164 - 164
  • [50] Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial
    Ang, Yuen-Siang
    Bruder, Gerard E.
    Keilp, John G.
    Rutherford, Ashleigh
    Alschuler, Daniel M.
    Pechtel, Pia
    Webb, Christian A.
    Carmody, Thomas
    Fava, Maurizio
    Cusin, Cristina
    McGrath, Patrick J.
    Weissman, Myrna
    Parsey, Ramin
    Oquendo, Maria A.
    McInnis, Melvin G.
    Cooper, Crystal M.
    Deldin, Patricia
    Trivedi, Madhukar H.
    Pizzagalli, Diego A.
    PSYCHOLOGICAL MEDICINE, 2022, 52 (13) : 2441 - 2449